<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Akoum, Nazem W.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">DECAAF</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-07-02 10:57:42</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">9-10</style></pages><abstract><style  face="normal" font="default" size="100%">Data from a cohort study of the DECAAF trial demonstrate that late gadolinium enhancement magnetic resonance imaging is a useful technique for identifying left atrial scarring following ablation of atrial fibrillation. Of 3 different ablation techniques, cryoablation produces more scarring than does point-by-point and multipolar RF ablation. Neither overall scar nor complete pulmonary vein encirclement was a significant predictor of arrhythmia recurrence.</style></abstract><number><style face="normal" font="default" size="100%">12</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>